Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 72; p. S16
Main Authors	Tolaney, S, Savulsky, C, Aktan, G, Xing, D, Almonte, A, Karantza, V, Diab, S
Format	Journal Article
Language	English
Published	01.02.2017
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049
DOI:	10.1016/S0959-8049(17)30131-4